Cargando…
A Rare Case of Regorafenib-Induced ST-Elevation Myocardial Infarction
Regorafenib is an oral multi-kinase inhibitor that is used in the treatment of chemotherapy-resistant metastatic colorectal carcinoma. However, multi-kinase inhibitors have been known to cause cardiac side effects, most notably hypertension. Myocardial ischemia is a very extraordinary adverse effect...
Autores principales: | Karki, Sadichhya, Deenadayalan, Vaishali, Shrestha, Prajwal, Dhungel, Samriddh, Vij, Aviral |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312477/ https://www.ncbi.nlm.nih.gov/pubmed/37398771 http://dx.doi.org/10.7759/cureus.39779 |
Ejemplares similares
-
A Rare Case Report of ST-Segment Elevation Myocardial Infarction and Recurrent Chest Pain in Polyarteritis Nodosa
por: Devarakonda, Pradeep Kumar, et al.
Publicado: (2021) -
A Rare Case of Myocarditis Mimicking ST-Elevation Myocardial Infarction
por: Fernando, Ashen, et al.
Publicado: (2020) -
Rare ST-Elevation Myocardial Infarction Mimic: Diabetic Ketoacidosis With Severe Hypercalcemia
por: Ahmed, Tamoor, et al.
Publicado: (2020) -
A Rare ST-Elevation Myocardial Infarction Mimic or a True Event?
por: Ahmed, Talha, et al.
Publicado: (2020) -
A Rare Case of ST-elevation Myocardial Infarction After Blunt Chest Trauma
por: Perez, Oscar, et al.
Publicado: (2020)